Transcription Factor BACH1 in Cancer: Roles, Mechanisms, and Prospects for Targeted Therapy

Authors

Dian Hu
Zerui Zhang
Xiangyuan Luo
Siwen Li
Junqing Jiang
Jiaqian Zhang
Zhangfan Wu
Yijun Wang
Mengyu Sun
Xiaoping Chen
Bixiang Zhang
Xiao Xu
Shuai Wang
Shengjun Xu
Yufei Wang
Wenjie Huang
Limin Xia

Publication Date

2-7-2024

Journal

Biomarker Research

Abstract

Transcription factor BTB domain and CNC homology 1 (BACH1) belongs to the Cap 'n' Collar and basic region Leucine Zipper (CNC-bZIP) family. BACH1 is widely expressed in mammalian tissues, where it regulates epigenetic modifications, heme homeostasis, and oxidative stress. Additionally, it is involved in immune system development. More importantly, BACH1 is highly expressed in and plays a key role in numerous malignant tumors, affecting cellular metabolism, tumor invasion and metastasis, proliferation, different cell death pathways, drug resistance, and the tumor microenvironment. However, few articles systematically summarized the roles of BACH1 in cancer. This review aims to highlight the research status of BACH1 in malignant tumor behaviors, and summarize its role in immune regulation in cancer. Moreover, this review focuses on the potential of BACH1 as a novel therapeutic target and prognostic biomarker. Notably, the mechanisms underlying the roles of BACH1 in ferroptosis, oxidative stress and tumor microenvironment remain to be explored. BACH1 has a dual impact on cancer, which affects the accuracy and efficiency of targeted drug delivery. Finally, the promising directions of future BACH1 research are prospected. A systematical and clear understanding of BACH1 would undoubtedly take us one step closer to facilitating its translation from basic research into the clinic.

Keywords

BACH1, Cancer, Immunity, Targeted therapy, Prognostic biomarker

Comments

PMID: 38321558